BlackRock Health Sciences Term Trust
BMEZ- Exchange
- NYSE
- SEC CIK
- 0001785971
No open-market purchases or sales by BlackRock Health Sciences Term Trust insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $255.0M in total; no superinvestor holds it.
Holders of 5% or more of BMEZ
Holders whose latest Schedule 13D or 13G filing reports 5% or more of BlackRock Health Sciences Term Trust, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | 13D/A | 19.98%20.8M shares | – | May 26, 202316 filings | Jan 21, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
19 Schedule 13D and 13G filings on BlackRock Health Sciences Term Trust, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 21, 202511:42 AM ET | Saba Capital Management, L.P.and 2 others | 13D/A | 19.98%20.8M shares | – | Jan 20, 2025 | SEC |
| Oct 11, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| May 21, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Mar 8, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 20, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Jan 31, 2024 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Dec 26, 2023 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Dec 13, 2023 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Dec 4, 2023 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Nov 20, 2023 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Nov 8, 2023 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Oct 24, 2023 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Oct 16, 2023 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 22, 2023 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| Aug 28, 2023 | Saba Capital Management, L.P. | 13D/AOld format | – | – | – | SEC |
| May 26, 2023 | Saba Capital Management, L.P. | 13DOld format | – | New | – | SEC |
| Dec 12, 20224:30 PM ET | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 9, 202212:11 PM ET | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 10, 20212:12 PM ET | Morgan Stanley | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell BlackRock Health Sciences Term Trust shares.
No Form 144 notices for BlackRock Health Sciences Term Trust are on file.